Surgical technique | ||||
---|---|---|---|---|
Characteristics | RRP | LRP | Total | p-value* |
Patients (n) | 168 | 171 | 339 | |
Age (yrs) | 0.678 MW | |||
Mean ± SD | 62.6 ± 5.4 | 62.3 ± 5.7 | 62.5 ± 5.6 | |
Median (Range) | 64 (43–73) | 64 (46–74) | 64 (43–76) | |
PSA (ng/ml) | 0.737 MW | |||
Mean ± SD | 10.1 ± 11.9 | 9.2 ± 6.9 | 9.7 ± 9.6 | |
Median (Range) | 7.4 (0.6-99.0) | 7.2 (0.6-50.6) | 7.4 (0.6-99.0) | |
Clinical stage (%) | 0.525 | |||
cT1 | 94/121 (77.7) | 120/167 (71.9) | 214/288 (74.3) | |
cT2 | 25/121 (20.7) | 43/167 (25.7) | 68/288 (23.6) | |
cT3 | 2/121 (1.7) | 4/167 (2.4) | 6/288 (2.1) | |
Biopsy Gleason score (%) | 0.328 | |||
≤ 6 | 78/146 (53.4) | 103/167 (61.7) | 181/313 (57.8) | |
7 | 52/146 (35.6) | 50/167 (29.9) | 1102/313 (32.6) | |
8-9 | 16/146 (11.0) | 14/167 (8.4) | 30/313 (9.6) | |
Pathology weight (g) | 0.024 MW | |||
Mean ± SD | 58 ± 22 | 53 ± 20 | 55 ± 21 | |
Median (Range) | 53 (27–150) | 49 (21–173) | 50 (21–173) | |
Prostatectomy Gleason score (%) | 0.533 | |||
≤ 6 | 49/161 (30.4) | 43/171 (25.1) | 92/332 (58.6) | |
7 | 91/161 (56.5) | 106/171 (62.0) | 197/332 (59.3) | |
8-9 | 21/161 (13.0) | 22/171 (12.9) | 43/332 (13.0) | |
Extraprostatic extension | 45/161 (28.0) | 51/171 (29.8) | 96/332 (28.9) | 0.798 |
Seminal vesicle invasion | 25/161 (15.5) | 10/171 (5.8) | 35/332 (10.5) | 0.008 |
Lymph node invasion | 14/156 (9.0) | 3/64 (4.7) | 17/220 (7.7) | 0.422 |
Positive surgical margin | 35/158 (22.2) | 45/170 (26.5) | 80/328 (24.4) | 0.435 |
pT2 R1 | 13 (10.5) | 21 (17.5) | 34 (13.9) | 0.006 |
Nerve sparing (%) | <0.001 | |||
None | 25/168 (14.9) | 92/171 (53.8) | 117/339 (34.5) | |
Unilaterally | 3/168 (1.8) | 39/171 (22.8) | 42/339 (12.4) | |
Bilaterally | 140/168 (83.3) | 40/171 (23.4) | 180/339 (53.1) | |
Time interval to interview (mo) | 0.222 | |||
Mean ± SD | 24 ± 16 | 24 ± 12 | 24 ± 14 | |
Median (Range) | 17 (9–62) | 22 (9–52) | 19 (9–62) |